Carisma Therapeutics, Inc. (CARM)
OTCMKTS
· Delayed Price · Currency is USD
0.0530
+0.0045 (9.28%)
At close: Dec 5, 2025
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $2.03 million as of December 5, 2025. Its market cap has decreased by -94.44% in one year.
Market Cap
2.03M
Enterprise Value
14.49K
Revenue
52.63M
Ranking
n/a
PE Ratio
0.25
Stock Price
$0.05
Market Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 2.03M, a decrease of -98.63%. That is a compound annual growth rate of -79.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 2.03M | -88.39% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 569.32M |
| Glass House Brands | 503.27M |
| CytoDyn | 416.55M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 359.36M |
| Silence Therapeutics | 298.99M |
| Nika Pharmaceuticals | 259.91M |